Luteolin Inhibits Lung Cancer Cell Migration by Negatively Regulating TWIST1 and MMP2 Through Upregulation of miR-106a-5p DOI Creative Commons
Qiang Wang, Mengyuan Chen, Xiaofang Tang

et al.

Integrative Cancer Therapies, Journal Year: 2024, Volume and Issue: 23

Published: Jan. 1, 2024

Background: Luteolin, a common dietary flavonoid found in plants, has been shown to have anti-cancer properties. However, its exact mechanisms of action non-small cell lung cancer (NSCLC) are still not fully understood, particularly role regulating broader genomic networks and specific gene targets. In this study, we aimed elucidate the microRNAs (miRNAs) NSCLC treated with luteolin, using A549 cells as model system. Materials Methods: miRNA profiling was conducted on luteolin-treated Exiqon microarrays, validation selected miRNAs by qRT-PCR. Bioinformatic analysis identified regulatory roles biological processes pathways following luteolin treatment. Computational algorithms were employed identify potential target genes. transfected miR-106a-5p mimic inhibitor or their corresponding controls. The expression levels 2 genes, twist basic helix-loop-helix transcription factor 1 (TWIST1) matrix metallopeptidase (MMP2), migration assessed. Results: 341 miRNAs, 18 exhibiting significantly altered ( P < 0.05). Subsequent qRT-PCR confirmed 6 miRNAs. KEGG GO analyses revealed significant alterations crucial for tumor biology. TWIST1 MMP2, which both contain conserved binding sites, exhibited an inverse correlation miR-106a-5p. Dual-luciferase reporter assays MMP2 direct targets Luteolin treatment led reduction migration, further amplified overexpression Conclusion: inhibits modulating landscape, shedding light laying foundation miRNA-based therapeutic approaches NSCLC.

Language: Английский

Therapeutic strategies targeting FOXO transcription factors DOI
Giampaolo Calissi, Eric W.‐F. Lam, Wolfgang Link

et al.

Nature Reviews Drug Discovery, Journal Year: 2020, Volume and Issue: 20(1), P. 21 - 38

Published: Nov. 10, 2020

Language: Английский

Citations

248

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies DOI Creative Commons

Zhijie Weng,

Yigan Wang,

Takehito Ouchi

et al.

Stem Cells Translational Medicine, Journal Year: 2022, Volume and Issue: 11(4), P. 356 - 371

Published: Jan. 29, 2022

Aging is a multifaceted and complicated process, manifested by decline of normal physiological functions across tissues organs, leading to overt frailty, mortality, chronic diseases, such as skeletal, cardiovascular, cognitive disorders, necessitating the development practical therapeutic approaches. Stem cell aging one theories organismal aging. For decades, mesenchymal stem/stromal cells (MSCs) have been regarded viable ideal source for stem cell-based therapy in anti-aging treatment due their outstanding clinical characteristics, including easy accessibility, simplicity isolation, self-renewal proliferation ability, multilineage differentiation potentials, immunomodulatory effects. Nonetheless, evidenced numerous studies, MSCs undergo functional deterioration gradually lose stemness with systematic age vivo or extended culture vitro, limiting applications. Even though our understanding processes behind MSC senescence remains unclear, significant progress has achieved elucidating aspects age-related phenotypic changes possible mechanisms driving senescence. In this review, we aim summarize current knowledge morphological, biological, stem-cell marker alterations MSCs, cellular molecular that underlie senescence, recent made regarding innovative techniques rejuvenate senescent combat aging, particular focus on interplay between niche well translational relevance. Also, provide some promising novel directions future research concerning

Language: Английский

Citations

161

Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities DOI Creative Commons
Zhao Huang, Zhe Zhang, Chengwei Zhou

et al.

MedComm, Journal Year: 2022, Volume and Issue: 3(2)

Published: May 18, 2022

Abstract Epithelial–mesenchymal transition (EMT) is a program wherein epithelial cells lose their junctions and polarity while acquiring mesenchymal properties invasive ability. Originally defined as an embryogenesis event, EMT has been recognized crucial process in tumor progression. During EMT, cell–cell cell–matrix attachments are disrupted, the cytoskeleton remodeled to enhance mobility of cells. This phenotype largely driven by group key transcription factors, typically Snail, Twist, ZEB, through epigenetic repression markers, transcriptional activation matrix metalloproteinases, reorganization cytoskeleton. Mechanistically, orchestrated multiple pathways, especially those involved such TGFβ, Wnt, Hedgehog, Hippo, suggesting intrinsic link between embryonic development cancer In addition, redox signaling also emerged critical modulator. confers with increased metastatic potential drug resistant capacity, which accounts for recurrence most clinic cases. Thus, targeting can be therapeutic option providing chance cure patients. Here, we introduce brief history summarize recent advances understanding mechanisms, well highlighting opportunities treatment.

Language: Английский

Citations

94

USP7 - a crucial regulator of cancer hallmarks DOI
Gouranga Saha, Srija Roy, Malini Basu

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2023, Volume and Issue: 1878(3), P. 188903 - 188903

Published: April 30, 2023

Language: Английский

Citations

46

Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives DOI Open Access
A K M Helal Morshed,

Supti Paul,

Arafat Hossain

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(7), P. 2128 - 2128

Published: April 3, 2023

Despite significant therapeutic advancements for cancer, an atrocious global burden (for example, health and economic) radio- chemo-resistance limit their effectiveness result in unfavorable consequences. Natural compounds are generally considered safer than synthetic drugs, use cancer treatment alone, or combination with conventional therapies, is increasingly becoming accepted. Interesting outcomes from pre-clinical trials using Baicalein medicines have been reported, some of them also undergone clinical later stages. As a result, we investigated the prospects Baicalein, naturally occurring substance extracted stems Scutellaria baicalensis Georgi Oroxylum indicum Kurz, which targets wide range molecular changes that involved development. In other words, this review primarily driven by findings studies therapy several cell populations based on promising research. The modifications numerous signal transduction mechanisms transcriptional agents highlighted as major players Baicalein’s anti-malignant properties at micro level. These include AKT serine/threonine protein kinase B (AKT) well PI3K/Akt/mTOR, matrix metalloproteinases-2 & 9 (MMP-2 9), Wnt/-catenin, Poly(ADP-ribose) polymerase (PARP), Mitogen-activated (MAPK), NF-κB, Caspase-3/8/9, Smad4, Notch 1/Hes, Signal transducer activator transcription 3 (STAT3), Nuclear factor erythroid 2-related 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap 1), Adenosine monophosphate-activated (AMPK), Src/Id1, ROS signaling, miR 183/ezrin, Sonic hedgehog (Shh) signaling cascades. promise anti-inflammatory to anti-apoptotic/anti-angiogenic/anti-metastatic medicinal element treating various malignancies its capability inhibit malignant stem cells, evidence synergistic effects, design nanomedicine-based drugs altogether supported data presented study.

Language: Английский

Citations

44

Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway DOI Creative Commons
Muhammad Tufail,

Jia-Ju Hu,

Jie Liang

et al.

Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: Jan. 3, 2024

Abstract Breast cancer (BC) is a multifaceted disease characterized by distinct molecular subtypes and varying responses to treatment. In BC, the phosphatidylinositol 3-kinase (PI3K) pathway has emerged as crucial contributor development, advancement, resistance This review article explores implications of PI3K in predictive, preventive, personalized medicine for BC. It emphasizes identification predictive biomarkers, such PIK3CA mutations, utility profiling guiding treatment decisions. The also discusses potential targeting preventive strategies customization therapy based on tumor stage, subtypes, genetic alterations. Overcoming inhibitors exploring combination therapies are addressed important considerations. While this field holds promise improving patient outcomes, further research clinical trials needed validate these approaches translate them into practice. Graphical

Language: Английский

Citations

25

The steroid hormone 20-hydroxyecdysone induces lipophagy via the brain-adipose tissue axis by promoting the adipokinetic hormone pathway DOI Creative Commons
Yan-Xue Li, Yan-Li Li, Xiao‐Pei Wang

et al.

Journal of Biological Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 108179 - 108179

Published: Jan. 1, 2025

Highlights:•The fat body undergoes lipophagy during insect metamorphosis.•The steroid hormone 20E upregulates Akh and Akhr expression.•The AKH pathway increases hemolymph glucose levels by promoting gluconeogenesis.•High promote FOXO acetylation nuclear localization to induce gene expression of lipophagy.AbstractLipophagy is a way degrade lipids; however, the molecular mechanisms are not fully understood. Using holometabolous lepidopteran Helicoverpa armigera, cotton bollworm, as model, we revealed that larval metamorphosis, essential for metamorphosis. The 20-hydroxyecdysone (20E) induced peptide adipokinetic (AKH, analog glucagon) receptor (AKHR). was highly expressed in brain various tissues. upregulated its EcR AKHR increased via gluconeogenesis promoted lipophagy. high level lipases autophagy genes. Thus, brain-adipose tissue axis pathway, which presented nutrients energy pupal adult development metamorphosis after feeding stops.

Language: Английский

Citations

2

Insights Into the Antiviral Pathways of the Silkworm Bombyx mori DOI Creative Commons
Liang Jiang

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: Feb. 11, 2021

The lepidopteran model silkworm,

Language: Английский

Citations

56

The role of SOX family transcription factors in gastric cancer DOI

Asal Jalal Abadi,

Ali Zarrabi,

Farid Hashemi

et al.

International Journal of Biological Macromolecules, Journal Year: 2021, Volume and Issue: 180, P. 608 - 624

Published: March 1, 2021

Language: Английский

Citations

56

FOXO3a in cancer drug resistance DOI
Ying Liu, Yu Wang, Xiaoge Li

et al.

Cancer Letters, Journal Year: 2022, Volume and Issue: 540, P. 215724 - 215724

Published: May 8, 2022

Language: Английский

Citations

54